Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;150(3):701-708.e4.
doi: 10.1016/j.jaci.2022.03.006. Epub 2022 Mar 18.

Strong and consistent associations of precedent chronic rhinosinusitis with risk of non-cystic fibrosis bronchiectasis

Affiliations

Strong and consistent associations of precedent chronic rhinosinusitis with risk of non-cystic fibrosis bronchiectasis

Brian S Schwartz et al. J Allergy Clin Immunol. 2022 Sep.

Abstract

Background: Chronic rhinosinusitis (CRS) and bronchiectasis commonly co-occur, but most prior studies were not designed to evaluate temporality and causality.

Objectives: In a sample representing the general population in 37 counties in Pennsylvania, and thus the full spectrum of sinonasal and relevant lung diseases, we aimed to evaluate the temporality and strength of associations of CRS with non-cystic fibrosis bronchiectasis.

Methods: We completed case-control analyses for each of 3 primary bronchiectasis case finding methods. We used electronic health records to identify CRS and bronchiectasis with diagnoses, procedure orders, and/or specific text in sinus or chest computerized tomography scan radiology reports. The controls never had any indication of bronchiectasis and were frequency-matched to the 3 bronchiectasis groups on the basis of age, sex, and encounter year. There were 5,329 unique persons with bronchiectasis and 33,363 without bronchiectasis in the 3 analyses. Important co-occurring conditions were identified with diagnoses, medication orders, and encounter types. Logistic regression was used to evaluate associations (odds ratios [ORs] and 95% CIs) of CRS with bronchiectasis while adjusting for confounding variables.

Results: In adjusted analyses, CRS was consistently and strongly associated with all 3 bronchiectasis definitions. The strongest associations for CRS (ORs and 95% CIs) were those that were based on the text of sinus computerized tomography scan reports; the associations were generally stronger for CRS without nasal polyps (eg, OR = 4.46 [95% CI = 2.09-9.51] for diagnosis-based bronchiectasis). On average, CRS was identified more than 6 years before bronchiectasis.

Conclusion: Precedent CRS was strongly and consistently associated with increased risk of bronchiectasis.

Keywords: Bronchiectasis etiology; epidemiology; risk factors; sinusitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: Dr. Kern serves as Chief Medical Officer for Lyra Therapeutics and has received consulting fees from Sanofi-Regeneron, Novartis/Genentech, and GSK. Dr. Tan has received consulting fees from Sanofi-Regeneron. Dr. Kato has received consulting fees from Astellas Pharma and a research gift from Lyra Therapeutics. Dr. Schleimer receives royalties from patents licensed by Johns Hopkins University to Allakos; has received consulting fees from Intersect ENT, Merck, GSK, Sanofi Regeneron, AstraZeneca/Medimmune, Genentech, Actobio Therapeutics, Lyra Therapeutics, Astellas Pharma, Allakos, and Otsuka; and owns stock in Allakos. Dr. Peters has received research grants or contracts from Sanofi Regeneron, Optinose, and AstraZeneca; and consulting fees from Sanofi-Regeneron, AstraZeneca, Optinose, and GSK. All other authors have nothing to disclose.

Figures

None
Overview of persons in the three case-control analyses, identifying unique persons and total sample sizes, Pennsylvania, 2010–2019. Concerning the overlap in case groups, from largest to smallest, there were 3,786 (71.1%) persons in the chest CT scan group only; 581 (10.9%) in all three case groups; 306 (5.7%) in diagnosis and order groups; 237 (4.5%) in the order only group; 189 (3.6%) in the order and text groups; 159 (3.0%) in the diagnosis only group; and 71 (1.3%) in the diagnosis and text groups. EHR = electronic health records.

Comment in

Similar articles

Cited by

References

    1. Guan WJ, Gao YH, Li HM, Yuan JJ, Chen RC, Zhong NS. Impacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with Bronchiectasis. PLoS One. 2015;10(9):e0137348. - PMC - PubMed
    1. Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. Nature reviews. Disease primers. Nov 15 2018;4(1):45. - PubMed
    1. Shteinberg M, Flume PA, Chalmers JD. Is bronchiectasis really a disease? Eur Respir Rev. Mar 31 2020;29(155). - PMC - PubMed
    1. Redondo M, Keyt H, Dhar R, Chalmers JD. Global impact of bronchiectasis and cystic fibrosis. Breathe (Sheff). Sep 2016;12(3):222–235. - PMC - PubMed
    1. Polverino E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. Sep 2018;52(3). - PubMed

Publication types